Coronavirus
Japan to pool $20bn with Europe, Canada for vaccine-buying fund
Smaller nations join forces to match US-China purchasing power
Biotechnology
Biotechnology
China's Sinopharm doubles output capacity for 2020 vaccine launch
Drugmaker's two plants can produce 200m doses as candidate moves through trials
Markets
Glove makers and net stocks see COVID-19 boom in bear market
80% of Asia300 issues fell in first half of 2020, led by airlines and energy
Pharmaceuticals
Samsung Biologics snags $1.5bn in orders on pandemic rush
South Korean drug-making powerhouse sees stock price double this year
Pharmaceuticals
Japan in talks to secure coronavirus vaccine from AstraZeneca
Daiichi Sankyo to distribute doses if UK development is successful
Coronavirus
Japan to ready 1m doses of coronavirus vaccine for swift distribution
AnGes-led team ramps up capacity while product is still under development
Biotechnology
SK Biopharm highlights drugs pipeline ahead of planned $800m IPO
South Korean drugmaker to start clinical test for anticancer treatment next year
Business deals
Takeda sells 18 drugs to South Korea's Celltrion in $278m deal
Products are sold in Australia, Malaysia, Philippines, Singapore and Thailand
Pharmaceuticals
Takara Bio cuts time for 5,000 coronavirus tests to two hours
Japanese biotech company reduces typical 1-day wait for results
Nikkei Asian Preview
Toyota AGM, Macao casino regulator, Vietnam-EU trade deal
Your weekly lineup of Asia's biggest business and political news
